Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Non Squamous NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05544929
What this trial is testing

Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Who this might be right for
Carcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more
Novartis Pharmaceuticals 126
Testing effectiveness (Phase 2)Ended earlyNCT06022757
What this trial is testing

Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)

Who this might be right for
CarcinomaSquamous Cell Carcinoma of Head and NeckUrothelial Carcinoma+5 more
Evopoint Biosciences Inc. 12
Large-scale testing (Phase 3)Looking for participantsNCT07291037
What this trial is testing

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 400
Testing effectiveness (Phase 2)Looking for participantsNCT06568939
What this trial is testing

Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 150
Testing effectiveness (Phase 2)Ended earlyNCT02093962
What this trial is testing

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
ImmunoGenesis 265
Early research (Phase 1)Looking for participantsNCT05208762
What this trial is testing

PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of the Head and NeckEsophageal Squamous Cell Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer 714
Testing effectiveness (Phase 2)Looking for participantsNCT06943820
What this trial is testing

AK129 Combination Therapy for Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVHead and Neck Squamous Cell Carcinoma (HNSCC)Colorectal Adenocarcinoma+1 more
Akeso 230
Large-scale testing (Phase 3)Looking for participantsNCT04181060
What this trial is testing

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Who this might be right for
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+2 more
National Cancer Institute (NCI) 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06982924
What this trial is testing

A Clinical Study on the Efficacy and Safety of the Combination of Limertinib and Bevacizumab Versus Limertinib as First-line Treatment for NSCLC.

Who this might be right for
EGFR Mutation Positive Advanced Non Small Cell Lung CancerPD-L1 Positive
Shanghai Chest Hospital 136
Testing effectiveness (Phase 2)Ended earlyNCT03347123
What this trial is testing

Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)

Who this might be right for
Solid Tumors
Incyte Corporation 11
Testing effectiveness (Phase 2)Study completedNCT01737502
What this trial is testing

Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+5 more
Mayo Clinic 29
Testing effectiveness (Phase 2)Looking for participantsNCT06427941
What this trial is testing

BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines 630
Testing effectiveness (Phase 2)Ended earlyNCT03496766
What this trial is testing

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 9
Early research (Phase 1)Study completedNCT02573259
What this trial is testing

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

Who this might be right for
Part 1MELANOMASCCHN+6 more
Pfizer 147
Testing effectiveness (Phase 2)Ended earlyNCT00365183
What this trial is testing

Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Carcinoma
Pharmacyclics LLC. 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT04736173
What this trial is testing

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNonsquamous Non Small Cell Lung CancerSquamous Non Small Cell Lung Cancer+1 more
Arcus Biosciences, Inc. 169
Testing effectiveness (Phase 2)Study completedNCT04350463
What this trial is testing

A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers

Who this might be right for
Neoplasms
Celgene 92
Not applicableLooking for participantsNCT07478809
What this trial is testing

A Retrospective Real-World Study Based on RATIONALE-307

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 109
Testing effectiveness (Phase 2)Looking for participantsNCT07227298
What this trial is testing

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Who this might be right for
Advanced/Metastatic Non-Small Cell Lung CancerCarcinoma, Non-Small Cell LungNon-Small Cell Lung Cancer
Pfizer 162
Testing effectiveness (Phase 2)Ended earlyNCT00998166
What this trial is testing

Cisplatin + Pemetrexed + Avastin as First-Line Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Columbia University 12
Next Page